Termination of Technology Licensing Agreement with Vical for Cytomegalovirus Prophylactic Vaccine
A project involving cytomegalovirus viremia prophylactic vaccine technology licensed from Vical, for which the technology licensing agreement ended upon expiration of its term.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.